Hunton & Williams LLP

Dan L. O’Korn has joined Hunton & Williams’ Raleigh office as a partner with its life science practice, a multidisciplinary group of more than 45 lawyers with patent, FDA, litigation and corporate experience. He joins the firm as part of its commitment to strengthen the firm’s biotechnology law practice in North Carolina, where he will focus on pharmaceutical and biotech transactions and FDA-related regulatory matters.

Mr. O’Korn has more than 13 years of legal experience, the majority of it devoted to the pharmaceutical industry. Most recently, he served as the vice president and general counsel of Xanodyne Pharmaceuticals, a privately owned pharmaceutical company committed to women’s health and pain management. Prior to that, he was senior corporate counsel at AAIPharma, Inc. in Wilmington, NC, where he served as lead attorney on several major product acquisitions and divestitures. Before joining AAIPharma Inc., he worked with Lilly, where he focused on complex product acquisitions and divestitures as well as general commercial transactions.

“Dan O’Korn is an invaluable addition to our firm,” says William S. Patterson, managing partner of the Raleigh office of Hunton & Williams. “The need for sophisticated counsel with life sciences experience continues to grow in the Triangle and elsewhere. Dan’s extensive background both complements our existing capabilities and adds a strong dimension of experience to our client service.”